Embed
Email

IOC Q3FY10 Result Update

Document Sample

Shared by: dffhrtcv3
Categories
Tags
Stats
views:
0
posted:
12/31/2011
language:
pages:
4
Emkay IOC Limited









Update

Result

Research Results inline with expectation, Maintain BUY



1st February, 2010 IOCL reported results which were inline with our estimates, primarily due to

budgetary support provided by the Government of India of Rs.44bn during the

BUY quarter. Revenue for the quarter was at Rs.652bn (against our expectation of

Rs.672bn), decline of 2.9%. EBITDA during the quarter was at Rs.17.2bn, decline

Price Target Price of 66.8% on a y-o-y basis. There was a fire incident at Jaipur terminal, amounting

to Rs. 2.8bn have been accounted during the quarter. Interest cost declined by

Rs.311 Rs.392

72.8% as debt levels have reduced significantly as compared to last year. During

the quarter the company reported net profit of Rs.6.9bn, decline of 76.5% on a y-o-

y basis.

Sensex – 16,358

During the quarter the company received budgetary support of Rs.71bn from the

GOI for the under-recovery of cooking fuel. However, this is substantially lower

than Rs.44.8bn of cooking fuel under-recovery that the company incurred for

9MFY10.



Though there has been some clarity on sharing mechanism (upstream companies

Price Performance sharing entire auto-fuel under-recovery), more budgetary support from GOI is

needed to keep IOCL in black. We expect GOI’s budgetary support to increase

(%) 1M 3M 6M 12M only if it is able to garner larger funds from disinvestment.

Absolute (2) (4) 10 38

Auto fuel under-recovery shared entirely by upstream

Rel. to Sensex 4 (6) 6 (22)

Source: Bloomberg We believe the highlight of IOCL’s results was the entire under-recovery of auto fuel

been shared by the upstream company. Upstream discount (pertaining to auto fuel

under-recovery) was Rs.43bn in Q3FY10 and Rs.20bn in Q2FY10. We believe these

are pointer towards proper sharing mechanism, auto fuel to be shared by upstream,

Stock Details cooking fuel by government.

Sector Oil & Gas

Reuters IOC.BO Budgetary Support towards under-recoveries on sales of LPG, Kerosene

Bloomberg IOCL@IN The Government of India has confirmed budgetary support of Rs.71bn to IOCL, of which

Equity Capital (Rs mn) 24280

Rs.44.8bn has been accounted for the nine months ended December ’09. The

Face Value (Rs ) 10

remaining amount will be accounted for in Q4FY10. We believe further budgetary

No of shares o/s (mn) 2428

support to OMC’s would largely depend on the disinvestment program of the

52 Week H/L (Rs ) 395/190

Market Cap (Rs bn /USD mn) 732/15,132

government and the amount that it collects through disinvestment.

Daily Avg Vol (No of shares) 984687

Daily Avg Turnover (US$ mn) 6.3 Interest cost significantly down

During the quarter, interest costs reduced by 72.8% to Rs.4bn as debt on the books

have reduced significantly. Net debt during Q3FY10 was at Rs.234bn. However, delay

Shareholding Pattern (%) in the issuance of oil bonds and recent increase in the crude oil prices might lead to

31/12/09 30/09//09 30/06/09 uptick in the interest cost in Q4FY10.

Promoters 78.9 78.9 78.9

FII/NRI 0.8 1.0 1.0 GRM at US$3.7 per bbl in Q3 FY10

Institutions 5.3 5.5 5.5 During the quarter, company has reported GRM of US$3.7 per bbl, which shrunk the

Private Corp. 9.4 9.2 9.2 average GRM from US$5.42 per bbl in 1HFY10 to US$4.84 per bbl in 9M FY10. For 9M

Public 5.6 5.4 5.4 FY10, GRM stands at US$ 4.84 per bbl compare to US$3.37 per bbl, up 44% on YoY

Source: Capitaline basis.



Valuation attractive, Maintain Buy

Amit Adesara We believe one of the highlights of the quarter was the entire under-recovery of auto

amit.adesara@emkayglobal.com fuel been shared by the upstream company as was the case in H1FY10. Though there

+91 22 6612 1241 has been some clarity on sharing mechanism (upstream companies sharing entire auto-

fuel under-recovery), more budgetary support from GOI is needed to keep IOCL in

Dhaval Joshi black. We expect GOI’s budgetary support to increase only if it is able to garner larger

dhaval.joshi@emkayglobal.com funds from disinvestment. At CMP, the stock trades at 1.5x and 1.3x FY10 and FY11

+91 22 6612 1282 P/BV. We maintain our BUY rating on the stock with target price of Rs.392.







Paragon Center, H -13 -16, 1st Floor, Pandurang Budhkar Marg, Worli, Mumbai – 400 013. India

IOCL L I M I T E D Result Update



Income Statement



Quarterly Result



Particulars Q3FY10 Q3FY09 Q2FY10 %YoY %QoQ

Net Sales 704097.7 705340.6 609697.0 -0.2 15.5

Net Sales 652257.2 612856.7 607873.0 6.4 7.3

Other Operating Income 7015.6 1654.0 1824.0 324.2 284.6

Govt of India (Special Oil Bonds) 44824.9 90829.9 0.0

Other Income 6782.8 18176.9 8481.1

Total Income 710880.5 723517.5 618178.1 -1.7 15.0

Total Expenditure 693625.2 671509.5 603559.1 3.3 14.9

Operating Profit 10472.5 33831.1 6137.9 -69.0 70.6

EBIDTA 17255.3 52008.0 14619.0 -66.8 18.0

Depreciation 7996.4 7275.3 7805.2

EBIT 9258.9 44732.7 6813.8

Interest 4090.7 15054.0 3477.2 -72.8 17.6

PBT 5168.2 29678.7 3336.6

Tax 1797.7 92.8 493.0 1837.2 264.6

PAT 6965.9 29585.9 2843.6 -76.5 145.0









Emkay Research 1 February 2010 2

IOCL L I M I T E D Result Update



Financials



Income statement Balance sheet

Rs. mn FY08 FY09 FY10E FY11E Rs. Mn FY08 FY09 FY10E FY11E

Revenue 2449691 3046261 2482089 2512892 Sources of Funds 819942 944439 988178 1053618

Expense 2346610 2983509 2308400 2359940 Shareholders Funds 410863 439982 528458 593898

Operating Profit 103081 62752 173690 152951 Equity Share Capital 11924 11924 24280 24280

OPM% 4 2 7 6 Reserves & Surplus 398939 428058 492038 545123

Other Income 41409 44274 37024 27954 Loan Funds 355232 449721 419721 399721

Depreciation 27097 28817 33708 38408 Deferred Tax Lia/(Ass) 53848 54736 40000 60000

PBIT 117393 78209 177006 142497 Application of Funds 818281 939878 981129 1053992

Interest 15512 39521 33578 31978 Fixed Assets 419420 525785 642077 718669

PBT 101491 42501 143428 110520 Gross Block 565182 617186 717186 817186

Tax 31178 11369 43028 33156 Less: Depreciation 239597 273262 306970 345377

PAT 70313 31132 100400 77364 Net Block 325586 343925 410217 471809

Capital WIP 93835 181861 231861 246861

Investments 215358 322321 377392 385009

Current Assets 529313 445352 247782 240612

Inventories 309415 251496 81603 82616

Debtors 68205 59379 20401 20654

Cash & Bank Balance 8244 7980 10897 2461

Loans & Advance 135547 115981 115981 115981

Other current Assets 7901 10516 18900 18900

Current Liabilities 345810 353580 286122 290298

Current Liabilities 328964 327546 260087 264264

Provisions 16846 26035 26035 26035





Cash Flow Kay Ratio

Rs. Mn FY08 FY09 FY10E FY11E FY08 FY09 FY10E FY11E

Profitability Ratio

Net Profit Before tax 100804 43286 143428 110520 EBITDA % 4.2 2.1 7 6.1

Depreciation 27074 30377 33708 38408 NPM% 2.9 1 4 3.1

Interest 15460 39521 33578 31978 ROCE% 9.3 3.6 14.2 10.9

WC Changes ROE% 17.1 7.1 19 13

Trade Receivables -1725 16313 -38978 253 Per share Data

Other receivables EPS 59 26.1 84.2 64.9

Inventory -62455 68976 169893 -1013 CEPS 81.7 50.3 112.5 97.1

Current Liabilities 66629 -9591 -67458 4176 BVPS 344.6 369 212.0 234.5

Operating cash flow -50301 -220016 265786 184322 Valuation Ratio

Direct Taxes paid -43609 7607 -43028 -33156 PE 10.9 24.5 7.6 9.9

Net Operating cash flow -93910 -212409 222758 151166 P/BV 1.9 1.7 1.5 1.3

Purchase of FA -69031 -126304 -100000 -100000 EV/EBITDA 7.3 12.3 5.2 6.1

Purchase of Investments 0 0 -130071 -77617 Gearing Ratio

Sale of Investments 93465 299388 75000 70000 Debt/Equity 0.9 1 0.8 0.7

Repayment of loans 0 0 -30000 -20000 Net Debt/Equity 0.4 0.4 0.5 0.5

Interest paid -17184 -43419 -33578 -31978

Dividend Paid -18134 -8484 -1192 -1192

Financing Cash Flow 49086 39504 -64770 -53170

Cash at the end 8244 7980 10897 2461









Emkay Research 1 February 2010 3

IOCL L I M I T E D Result Update









DISCLAIMER: This document is not for public distribution and has been furnished to you solely for your information and may not be reproduced or redistributed to any other person. The

manner of circulation and distribution of this document may be restricted by law or regulation in certain countries, including the United States. Persons into whose possession this document may

come are required to inform themselves of, and to observe, such restrictions. This material is for the personal information of the authorized recipient, and we are not soliciting any action based

upon it. This report is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. No person

associated with Emkay Global Financial Services Ltd. is obligated to call or initiate contact with you for the purposes of elaborating or following up on the information contained in this document.

The material is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon. Neither Emkay Global Financial

Services Ltd., nor any person connected with it, accepts any liability arising from the use of this document. The recipient of this material should rely on their own investigations and take their own

professional advice. Opinions expressed are our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed in

this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not

predictions and may be subject to change without notice. We and our affiliates, officers, directors, and employees world wide, including persons involved in the preparation or issuance of this

material may; (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving

such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform

investment banking services for such company(ies)or act as advisor or lender / borrower to such company(ies) or have other potential conflict of interest with respect to any recommendation

and related information and opinions. The same persons may have acted upon the information contained here. No part of this material may be duplicated in any form and/or redistributed without

Emkay Global Financial Services Ltd.'s prior written consent. No part of this document may be distributed in Canada or used by private customers in the United Kingdom. In so far as this report

includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed.



Emkay Global Financial Services Ltd.

Paragon Center, H -13 -16, 1st Floor,

Pandurang Budhkar Marg, Worli, Mumbai – 400 013.

Tel no. 6612 1212. Fax: 6624 2410









Emkay Research 1 February 2010 4



Related docs
Other docs by dffhrtcv3
Chromosomal Miss-Segregation and DNA Damage
Views: 23  |  Downloads: 0
Christmas
Views: 21  |  Downloads: 0
Christmas Party Counting
Views: 19  |  Downloads: 0
Christmas dishes
Views: 19  |  Downloads: 0
CHRISTIAS FOR BIBLICAL ISRAEL or CFBI
Views: 20  |  Downloads: 0
Christian Ethics Living a Responsible Life
Views: 20  |  Downloads: 0
Christian Duty - Seymour Church of Christ
Views: 20  |  Downloads: 0
Chp 9 Power Point 08-09
Views: 19  |  Downloads: 0
Choose Your Own Adventure 2
Views: 20  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!